Why do we need Personalized Medicine
Online Training Id: PPD-002
Geographical Region: All
Duration: 2 hrs
This module will describe personalized medicine and why it is required. The topics covered will include:
Genomics: How genomics data are being sequenced and collated gathered;
Use of genomics data in drug discovery;
Biomarkers in disease detection; and
Delivery of personalized medicine: targeted therapeutics
At the end of the module, the delegate will be have an overview of current activities in genomics, their translation into new drug discovery and the delivery of personalized medicine.
Who Should Enroll:
All Research based Pharmaceutical Scientist
Claire is a Co-founder and Director at NanoScientium. Prior to this she was Head of Research and Development with Oxford Pharmascience, an AIM-listed Pharma company identified as one of the "Top 10 Emerging Technology Companies 2012". Oxford Pharmascience develops cutting edge technologies to enable medicines to be safer and easier to take. Prior to this, Claire spent 7½ years in Contract Research Organisations and large Pharma (Pfizer and GSK) developing novel molecules and formulations for therapeutic areas such as asthma, cancer, HIV, insomnia, malaria and pain. She attained increasingly senior roles leading global technical teams across R&D and manufacturing to deliver projects to milestones throughout the development lifecycle.
Claire was appointed Chief Scientist of the Academy of Pharmaceutical Sciences in June 2012 and has been a Board Member of the organisation since 2008. Claire holds a PhD from School of Pharmacy, University of Nottingham, and a BSc in Biochemistry from University of St. Andrews.
Dr Claire Thompson
CO-FOUNDER AND DIRECTOR AT NANOSCIENTIUM